Securities Code: 002898
Securities Abbreviation: Sailong Delisting
Announcement Number: 2026-077
Sailong Pharmaceutical Group Co., Ltd.
Fifth Risk Warning Announcement on Company Stock Entering Delisting Arrangement Period
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
Special Risk Warning:
-
Sailong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") stock will be delisted on the next trading day after the delisting arrangement period ends, and the company's stock will be terminated from listing.
-
The company's stock resumed trading and entered the delisting arrangement period on June 26, 2026. The delisting arrangement period is fifteen trading days, and the expected last trading day is July 16, 2026. This announcement is disclosed on the twelfth trading day, with three remaining trading days. The stock will be terminated from listing upon the expiration of the trading period. Investors are urged to invest prudently and pay attention to risks.
-
During the trading period of the company's stock in the delisting arrangement period, the company will not plan or implement major asset restructurings.
-
Investors, securities companies, and other market participants are requested to settle stock pledge repurchase, agreement repurchase, margin financing, securities lending, and other businesses in a timely manner before the stock delisting.
-
For judicial freezing businesses that expire after the stock delisting and before the initial registration period of the two-network company and delisted company board managed by Shenzhen Securities Transfer Exchange Co., Ltd. on behalf of the original securities company (hereinafter referred to as the "Delisting Board"), it is recommended that the competent authorities handle the renewal of the freezing procedures through the original assisting execution channels before the stock delisting.